Eledon Pharmaceuticals
ELDN
ELDN
35 hedge funds and large institutions have $52.1M invested in Eledon Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less capital invested
Capital invested by funds: $74.5M → $52.1M (-$22.4M)
Holders
35
Holding in Top 10
–
Calls
$80K
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$1.54M | |
| 3 | +$705K | |
| 4 |
Two Sigma Investments
New York
|
+$357K |
| 5 |
Two Sigma Advisers
New York
|
+$232K |
Top Sellers
| 1 | -$4.59M | |
| 2 | -$2.74M | |
| 3 | -$2.13M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$1.93M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$682K |